| C | ||||
| Placebo | 0.11 (−0.26 to 0.47) | 0.95 (0.50 to 1.40) | ||
| 0.93 (0.23 to 1.63) | Steroid Inj | 0.16 (−0.47 to 0.79) | 0.02 (−0.51 to 0.56) | |
| 0.11 (−0.26 to 0.47) | −0.82 (−1.61 to -0.03) | Orthoses | ||
| 1.09 (0.15 to 2.03) | 0.16 (−0.47 to 0.79) | 0.98 (−0.03 to 1.99) | Exe | |
| 0.95 (0.50 to 1.40) | 0.03 (−0.51 to 0.56) | 0.84 (0.26 to 1.43) | −0.14 (−0.96 to 0.69) | ESWT |
Summary estimates from the network meta-analysis are shown in lower left triangle, and summary estimates from pairwise meta-analysis (ie, direct evidence) in upper right triangle. Each cell shows a standardised mean difference (SMD), with a 95 % CI in parentheses. For any cell, a negative SMD favours the upper-left intervention, and a positive SMD favours the lower-right intervention. Significant results in bold text.
ESWT, extracorporeal shockwave therapy; Exe, exercise; Orthoses, prefabricated or customised foot orthoses; Placebo, usual care/placebo; Steroid Inj, corticosteroid injection; Steroid Inj+Exe, corticosteroid injection combined with exercise.